"post-capillary PH" (3), or "passive PH" (4) . This type of PH is distinct from primary pulmonary arterial hypertension where there is no increase in left ventricular filling pressure (i.e., pre-capillary PH).
Patients with left ventricular dysfunction (LVD)
may develop a pre-capillary pulmonary arterial contribution to PH, reflected by an increased transpulmonary gradient (TPG), defined as mPAP-PCWP that exceeds 12 to 15 mm Hg, or an elevated pulmonary vascular resistance (PVR), defined as TPG/ cardiac output that exceeds 2.5 to 3 Wood units (5, 6) . This type of PH, which is "out of proportion" to underlying left-sided disease in the setting of normalized volume status, has been termed "mixed PH," given both pre-capillary and post-capillary contributions to elevated PAP. In patients with LVD, a high pre-capillary contribution to PH has been associated with reduced exercise capacity (5,7), inefficient ventilation (8) , and increased mortality in some studies (6,9-11) but not others (12) . While a precapillary contribution to PH in LVD has historically been defined by an elevated TPG or PVR, there has been a recent shift in focus to pulmonary arterial diastolic pressure gradient (DPG), defined as: diastolic PAP -PCWP (mm Hg) (13) . In comparison with TPG and PVR, DPG has been shown to be less sensitive to changes in left atrial pressure or changes in stroke volume (14) , and therefore has been proposed to be a higher fidelity marker of pre-capillary pulmonary arterial remodeling and dysfunction in LVD (13, 15, 16) .
At a time when the nomenclature and optimal assessment of PH-LVD continue to evolve (4, 13) and the value of PH-LVD as a prognostic marker and therapeutic target remain under debate (17) , the study by Tampakakis et al. (18) precise hemodynamic measurements; 2) the thorough investigation of multiple potential cut points for DPG, TPG, and PVR as they relate to prognosis; and 3) the fulfillment of an unmet need to further investigate the prognostic significance of DPG, which was incorporated into recommendations of the 5th World Symposium on Pulmonary Hypertension (13) as the metric of choice for assessing pre-capillary PH in LVD based largely on a single outcomes study (15) .
To put the findings by Tampakakis et al. (18) into context, it is important to examine the population studied in detail. The subjects were relatively young (average age 50 years) with a paucity of ischemic etiology of cardiomyopathy (7%). PH prevalence (40%) was lower than that reported in community cohorts of heart failure (79%) (19) as well as prevalence rates in heart failure referral populations (63% to 73%) (5,9).
In addition, the prevalence of pre-capillary PH varied by the metric utilized (13% as defined by DPG $7 mm Hg; 31% as defined by TPG >12 mm Hg; 38% as defined by PVR $3 Wood units) and was similarly less prevalent than rates reported from studies performed in other heart failure populations (36% to 50%) (5, 20) .
Young age and relatively new onset heart failure may explain the relatively low prevalence of PH in this cohort. Although comprehensive data was not available on co-morbidities, it is likely that conditions known to influence DPG (e.g., chronic obstructive pulmonary disease) (21) and/or PAP (e.g., reduced creatinine clearance, atrial fibrillation, anemia) (2, 19) were relatively unrepresented in this population compared to the broader heart failure population. In contrast, the relationship between PVR and mortality was highly significant in adjusted analysis (p ¼ 0.002). Given the known relationship between PH and functional capacity in LVD (3,4) , the investigation of additional endpoints beyond all-cause mortality (e.g., peak VO 2 , 6-min walk distance, heart failure hospitalizations) would have been of particular interest. Despite these limitations, the null findings of this study suggest that, in the heart failure community, widespread use of DPG as a prognostic variable may be premature, and that it is necessary to carefully compare this study to the previous landmark study of Gerges et al. (15) that drew opposite conclusions.
DPG: WEIGHING ADVANTAGES AND DISADVANTAGES OF ITS MEASUREMENT
Recent work has highlighted the important relationship between increasing left atrial pressure (LAP) and increasing pulmonary artery wave reflections due to reduced arterial compliance, with subsequent augmentation of pulmonary artery systolic pressures (22) . As a result, mPAP and measurements that incorporate mPAP (TPG and PVR) are influenced by the degree of elevation in LAP/PCWP and therefore lack specificity as indicators of pulmonary vascular remodeling and dysfunction. To that end, DPG is an attractive descriptive metric of pre-capillary PH that is relatively immune to variability in cardiac output as well as the influence of elevated LAP on pulmonary arterial compliance (13, 14) . However, the findings of In contrast to both of these studies, Gerges et al. (15) found that elevated DPG ($7 vs. <7 mm Hg) was associated with worse median survival in patients with left heart disease (LHD) with PH and TPG >12 mm Hg. The study by Gerges et al. (15) In summary, the study from Tampakakis et al. (18) highlights the descriptive and prognostic limitations of using resting DPG as an isolated measure of precapillary PH in a "real-world" heart failure referral glewis@partners.org.
